XinRong Medical Group has recently appointed Mr. Stephen Ooi as a member of the board of directors.
BEIJING, July 19, 2017 /PRNewswire/ -- Mr. Stephen Ooi has had more than 36 year of work experience in the Medical Device industry. Before assuming his current
"The opportunities for XinRong Medical in the China market and beyond are exciting. Strong Leadership and strategic focus to win the hearts of customers through strong customer service and quality products are keys to success. The passion of the leadership team in XinRong is clearly palpable and it is my honor and privilege to be given the opportunity to work with the team. It's an exciting time, and with Blackstone's support, we have the right ingredients to be successful in China. I look forward to working with the team," said, Mr. Stephen Ooi, Independent Director of XinRong Medical Group.
"The Chinese Orthopedic market has become one of the world's largest orthopedic markets driven by an aging population, increasing disease prevalence, improving treatment rate and growing affordability. We believe our foremost responsibility is to provide surgeons and patients with products and services that are of the highest quality. We are excited to have Stephen Ooi join the XinRong Medical team. With his rich industry experience and passion in managing talent, we look forward to working closely with Stephen in continuing to grow XinRong Medical as an industry leader," added Ms. Christine (Yu) Zhang, XinRong Medical Group's CEO.
About XinRong Medical Group
XinRong Medical Group, a leader in medical technology, is dedicated to increasing patient affordability and providing the most advanced solutions for surgeons such that they can deliver the best patient care. XinRong Medical offers innovative solutions in orthopedic surgery, neurosurgery, reconstructive surgery, and minimally invasive therapy.
Established in 2000 in Jiangsu Province, China, XinRong Medical was one of the first companies in China cleared by SFDA to manufacture Orthopedic Implants. In 2014, the Company received a strategic investment from The Blackstone Group (NYSE: BX).
For additional information about XinRong Medical, please refer to our website www.XRBest.Com, or contact us directly at +86-512-58100828 or email@example.com.
View original content:http://www.prnewswire.com/news-releases/mr-stephen-ooi-former-zimmer-executive-newly-appointed-as-independent-board-director-of-xinrong-medical-300490651.html
SOURCE XinRong Medical
Subscribe to our Free Newsletters!
Learn the basics about diabetes and how to bring it under control with turmeric, an highly ...
Antioxidants are artificial or natural components that help protect the human body from the damage ...
Angiogenesis is the process of formation of new blood vessels from pre-existing blood vessels. It ...View All